Abigail Farrell Kamertz, NP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 20 Herr Dr, Nottingham, PA 19362 Phone: 610-871-7696 |
News Archive
Evidence is accumulating that depression is a risk factor for osteoporosis, reports the June 2007 issue of Harvard Women's Health Watch.
CitiusTech announced today that BI-Clinical Framework 10.3 is 2011/2012 compliant and was certified as an EHR Module on May 12, 2011 by the Certification Commission for Health Information Technology, an ONC-ATCB, in accordance with the applicable Eligible Hospital certification criteria adopted by the Secretary of Health and Human Services.
Interest in research into the effects of psilocybin, a psychedelic drug, has increased significantly in recent years due to its promising therapeutic effects in neuropsychiatric disorders such as depression, anxiety and addiction.
Debiopharm Group, a global biopharmaceutical development specialist that focuses on serious medical conditions and particularly oncology, and Ascepion Pharmaceuticals, Inc., a privately-held, biopharmaceutical company dedicated to the discovery and development of breakthrough small molecule drugs for the treatment of oncology and related diseases, have entered into an exclusive worldwide license agreement concerning the development and commercialization of ASP-08126 (called Debio 1144 by Debiopharm) a multikinase inhibitor currently in pre-clinical development.
› Verified 5 days ago